Clinical Infection in Practice (Apr 2022)
Multi inflammatory syndrome in a 16-year-old male following first dose of m-RNA COVID-19 vaccination
Abstract
Multisystem Inflammatory Syndrome (MIS) is an uncommon systemic illness that occurs 4–6 weeks after primary infection with SARS-CoV-2. There are emerging reports of MIS arising following vaccination against SARS-CoV-2. We report a 16-year-old male with a multi system inflammatory condition meeting the case definition for MIS following BTN162b2 mRNA SARS-CoV-2 (Pfizer BioNTech) vaccine with no other identifiable precipitant or evidence of primary infection with SARS-Cov-2.